NewAge is a Colorado-based organic and healthy products company dedicated to inspiring and educating consumers to “Live Healthy.” The Company is an omni-channel distribution company with access to traditional retail, e-commerce, direct-to-consumer, and medical channels across more than 75 countries worldwide when combined with ARIIX. NewAge markets a portfolio of differentiated healthy functional brands in three category platforms including Health & Wellness, Healthy Appearance, and Nutritional Performance. The Company operates the websites newage.com, noninewage.com, and a number of other individual brand websites.

Our history is one of continuous innovation and brand-building, capturing significant brand and revenue growth since our founding in 2003. Originally a distribution company with a single brand, Aspen Pure water, all-natural Xing Tea was created in the interest of giving consumers an alternative to the artificial, unhealthy offerings of mainstream competitors. Xing has since diversified their product with the formation of Xing Energy, an all-natural, non-GMO energy drink. In June of 2016, New Age Beverages Corporation was formed with the acquisition of Aspen Pure and Xing Beverages by Búcha Live Kombucha. 

Chief Executive Officer| Brent Willis

Mr. Willis has served as our Chief Executive Officer since March 2016. Prior to serving as Chief Executive Officer for New Age, he held senior leadership positions at Kraft Foods, ABInBev and served as a President in Latin America for the Coca-Cola Company. Mr.Willis has 20+ years of General Management, C-Level, Board, and Private Equity experience with global leaders in the CPG space. He holds a Bachelor of Science degree in Engineering from the U.S. Military Academy at West Point in 1982 and an MBA from the University of Chicago in 1991.

---

Chief Financial Officer| Gregory A. Gould

Mr. Gould has served as our Chief Financial Officer since October 2018. Prior to joining the Company, Mr. Gould served as Chief Financial Officer of Therapure-Products (Evolve Biologics), a subsidiary of Therapure BioPharma, Inc., from November 2017 until October 2018. Mr. Gould also served as Chief Financial Officer, Treasurer and Secretary of Aytu BioScience, Inc., or Aytu (NASDAQ: AYTU), from April 2015 until November 2017, and he was the Chief Financial Officer, Secretary and Treasurer of Ampio Pharmaceuticals, Inc., or Ampio (NASDAQ: AMPE), from June 2014 until June 2017. He has held CFO and Principal Accounting Officer roles at several publicly traded corporations and has served as an independent board member and accounting expert. He is a highly accomplished financial executive with expertise in the life sciences industry. Mr. Gould is a CPA in the state of Colorado. He holds a Bachelor of Science in Business Administration from the University of Colorado, Boulder.

---